John Paulson bought $21M of BHC
director at Bausch Health Companies Inc.. 3,243,049 shares at an average of $6.56, traded Aug 11, 2025, filed Aug 13, 2025.
Score components
- +15RoleDirector
- +25Trade size$21.3M at market
- +3Relative to holdingsHoldings up 10%
- +8Price context32% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001013594-25-001002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 11, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +2,000,000 | $6.35 | $13M | 34,791,702 | Aug 13, 2025 |
| Aug 12, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +1,156,640 | $6.88 | $8.0M | 35,948,342 | Aug 13, 2025 |
| Aug 13, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +86,409 | $7.06 | $610k | 36,034,751 | Aug 13, 2025 |
Related signals
Other insiders at Bausch Health Companies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | BHCbuy Bausch Health Companies Inc. | Paulson & Co. Inc. owner | $16M 2,500,000 shares | +4% | |
| 5Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $98k 13,370 shares | -3% | |
| 30Weak | BHCsell Bausch Health Companies Inc. | Frank D. Lee director | $122k 15,912 shares | -18% | |
| 59Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $312M 34,721,118 shares | +96% | |
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,564,059 shares | +12% | |
| 51Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $15M 2,788,608 shares | +11% | |
| 0Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $3,674 440 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.